Granuloma Formation around Filarial Larvae Triggered by Host Responses to an Excretory/Secretory Antigen

ABSTRACT In previous studies using a murine model of filarial infection, granuloma formation was found to be a most important host-protective mechanism. We have also shown that in vitro cytoadherence is a surrogate for the formation of antifilarial granulomas in vivo and that it requires “alternatively activated” host cells and a source of antifilarial antibody. We show here that antibodies against L3 excretory/secretory (E/S) products can facilitate in vitro cytoadherence. We generated a set of hybridomas reactive with filarial E/S products and screened them for their ability to mediate in vitro cytoadherence. One clone (no. 1E9) was positive in this assay. We then screened a novel expression library of filarial antigens displayed on the surface of T7 bacteriophage for reactivity with 1E9. Phage expressing two filarial antigens (TCTP and BmALT-2) reacted with 1E9. Immunization of mice showed that the cohort immunized with BmALT-2 cleared a challenge infection with infective Brugia pahangi L3 in an accelerated manner, whereas cohorts immunized with TCTP cleared larvae with the same kinetics as in unimmunized mice. These data confirm that BmALT-2 is the antigenic target of granuloma-mediated killing of B. pahangi L3. Our findings also confirm previous studies that BmALT-2 is a potential vaccine candidate for filarial infection. Our data reinforce the work of others and also provide a possible mechanism by which immune responses to BmALT-2 may provide host protection.

[1]  C. McGuiness,et al.  THE L3 TO L4 MOLT OF BRUGIA MALAYI: REAL TIME VISUALIZATION BY VIDEO MICROSCOPY , 2005, The Journal of parasitology.

[2]  I. Kalajzic,et al.  Ascorbic Acid Is a Requirement for the Morphogenesis of the Human Filarial Parasite Brugia malayi , 2003, The Journal of parasitology.

[3]  L. Shultz,et al.  Brugian infections in the peritoneal cavities of laboratory mice: kinetics of infection and cellular responses. , 2002, Experimental parasitology.

[4]  Jianzhu Chen,et al.  Enhanced B-1 cell development, but impaired IgG antibody responses in mice deficient in secreted IgM. , 1998, Journal of immunology.

[5]  P. Pandiaraja,et al.  Brugia malayi: comparison of protective immune responses induced by Bm-alt-2 DNA, recombinant Bm-ALT-2 protein and prime-boost vaccine regimens in a jird model. , 2007, Experimental parasitology.

[6]  W. F. Gregory,et al.  The Abundant Larval Transcript-1 and -2 Genes ofBrugia malayi Encode Stage-Specific Candidate Vaccine Antigens for Filariasis , 2000, Infection and Immunity.

[7]  J. Franssen,et al.  Monoclonal antibodies against urokinase , 1981, Bioscience reports.

[8]  L. Shultz,et al.  B1 B Lymphocytes Play a Critical Role in Host Protection against Lymphatic Filarial Parasites , 2000, The Journal of experimental medicine.

[9]  L. Shultz,et al.  T Cells Are Required for Host Protection against Brugia malayi but Need Not Produce or Respond to Interleukin-4 , 2003, Infection and Immunity.

[10]  M. Boes,et al.  Role of natural and immune IgM antibodies in immune responses. , 2000, Molecular immunology.

[11]  F. K. Nelson,et al.  The immunodeficient scid mouse as a model for human lymphatic filariasis , 1991, The Journal of experimental medicine.

[12]  J. McCarthy,et al.  The Larval Specific Lymphatic Filarial ALT‐2: Induction of Protection Using Protein or DNA Vaccination , 2004, Microbiology and immunology.

[13]  F. K. Nelson,et al.  Infectivity and normal development of third stage Brugia malayi maintained in vitro. , 1994, The Journal of parasitology.

[14]  Linda A. Murray,et al.  Abundant larval transcript-1 and -2 genes from Brugia malayi: diversity of genomic environments but conservation of 5' promoter sequences functional in Caenorhabditis elegans. , 2002, Molecular and biochemical parasitology.

[15]  V. Pandey,et al.  Evaluation of immunoprophylactic efficacy of Brugia malayi transglutaminase (BmTGA) in single and multiple antigen vaccination with BmALT-2 and BmTPX for human lymphatic filariasis. , 2009, The American journal of tropical medicine and hygiene.

[16]  P. Kaliraj,et al.  Comparison of immunogenicity, protective efficacy of single and cocktail DNA vaccine of Brugia malayi abundant larval transcript (ALT-2) and thioredoxin peroxidase (TPX) in mice. , 2008, Acta tropica.

[17]  T. Nutman,et al.  Novel Phage Display-Based Subtractive Screening To Identify Vaccine Candidates of Brugia malayi , 2004, Infection and Immunity.

[18]  T. Ramalingam,et al.  Critical Role for IgM in Host Protection in Experimental Filarial Infection , 2005, The Journal of Immunology.